Prof. Dr. Özlem Üstay

Comprehensive biochemical and radiological assessment of clinical characterization pertaining to bilateral adrenal masses: a multi-center cross-sectional investigation

Endocrine, 2026

DOI 10.1007/s12020-026-04667-8 PMID 42213231 Açık erişimli tam metinKaynak: OpenAlex

P-095 HIGH RISK PAPILLARY THYROID CARCINOMA IN A BRANCHIAL CLEFT CYST PRESENTING WITH CERVICAL LYMPH NODE METASTASIS

JCEM Case Reports, 2026

DOI 10.1210/jcemcr/luaf297.079 Açık erişimli tam metinKaynak: OpenAlex

P-055 MONOZYGOTIC TRANSGENDER MALE TWINS: A CASE REPORT HIGHLIGHTING GENETIC CONCORDANCE IN GENDER DYSPHORIA

JCEM Case Reports, 2026

DOI 10.1210/jcemcr/luaf297.043 Açık erişimli tam metinKaynak: OpenAlex

P-107 INCIDENTAL RENAL PRESENTATION OF PAPILLARY THYROID CARCINOMA: A RARE CASE REPORT

JCEM Case Reports, 2026

DOI 10.1210/jcemcr/luaf297.086 Açık erişimli tam metinKaynak: OpenAlex

O-10 AN OVARIAN THECOMA PRESENTING WITH POST-MENOPAUSAL VIRILIZATION

JCEM Case Reports, 2025

DOI 10.1210/jcemcr/luae218.034 Açık erişimli tam metinKaynak: OpenAlex

P-06 WHEN IS GENDER SELECTION IN CONGENITAL ADRENAL HYPERPLASIA?

JCEM Case Reports, 2025

DOI 10.1210/jcemcr/luae218.009 Açık erişimli tam metinKaynak: OpenAlex

P-50 WE KNOW YOU ARE THERE: MISSING MASS

JCEM Case Reports, 2025

DOI 10.1210/jcemcr/luae218.052 Açık erişimli tam metinKaynak: OpenAlex

P-10 CUSHING'S SYNDROME WITH ATYPICAL ADRENAL MASS AND ELEVATED 17-HYDROXYPROGESTERONE: A DIAGNOSTIC CHALLENGE

JCEM Case Reports, 2025

DOI 10.1210/jcemcr/luae218.011 Açık erişimli tam metinKaynak: OpenAlex

Endokrin Aciller

Akademisyen Kitabevi eBooks, 2024

DOI 10.37609/akya.2879 Açık erişimli tam metinKaynak: OpenAlex

Erdheim-chester disease: a case report with pituitary involvement

Endocrine Abstracts, 2024

DOI 10.1530/endoabs.99.ep1024 Kaynak: OpenAlex

Endocrine-disrupting effects of bisphenol-A, thiamethoxam, and fipronil in hormone-naïve transmen compared to cis-women

Hormones, 2024

DOI 10.1007/s42000-024-00574-7 PMID 38990460 Açık erişimli tam metinKaynak: ORCID

Hyperandrogenism-related metabolic changes in drug-naïve transmen compared to cisgender women: a case-controlled study

Endokrynologia Polska, 2023

DOI 10.5603/ep.a2023.0052 PMID 37577993 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

Exogenous Testosterone May Have A Effect on Thyroid Volume İn Trans-Men

Endocrine Abstracts, 2023

DOI 10.1530/endoabs.90.p230 1 atıf (OpenAlex) Kaynak: OpenAlex

A case of primary ovarian failure with Nijmegen Breakage a chromosomal instability syndrome

JCEM Case Reports, 2023

DOI 10.1210/jcemcr/luac014.050 Açık erişimli tam metinKaynak: OpenAlex

Hyperandrogenism-related metabolic changes in drug-naive transmen compared to cisgender women: A case-controlled study

Endocrine Abstracts, 2023

DOI 10.1530/endoabs.90.p177 Kaynak: OpenAlex

When do we need to suspect maturity onset diabetes of the young in patients with type 2 diabetes mellitus?

Archives of Endocrinology and Metabolism, 2022

DOI 10.20945/2359-3997000000431 PMID 35029855 3 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

Vitamin D receptor and estrogen receptor gene polymorphisms in men with type 2 diabetes: Effects on Bone Metabolism.

Journal of diabetes and metabolic disorders, 2022

DOI 10.1007/s40200-022-01048-6 PMID 36404811 4 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

Hormon naif transerkeklerde endokrin bozucu etkilerin Tiyometoksam, Fipronil ve Bisfenol-A düzeyleri ile incelenmesi: tek merkez vaka control çalışma

Dspace Repository (Marmara Üniversitesi), 2022

Kaynak: OpenAlex

Genetic and Clinical Characterization of Patients with Maturity-Onset of Diabetes of the Young (MODY): Identification of Novel Variations

Balkan Medical Journal, 2021

DOI 10.5152/balkanmedj.2021.20155 PMID 34462253 5 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

Serum Paraoxonase-1 Activity and Paraoxonase Q192 Gene Polymorphism in a Young, Healthy Population

Endocrinology research and practice., 2021

DOI 10.25179/tjem.2020-80427 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

SGLT2 inhibitors improve plasma atherogenic biomarkers in patients with type 2 diabetes: a real world retrospective observational study.

Minerva endocrinology, 2021

DOI 10.23736/s2724-6507.21.03465-5 PMID 33979071 17 atıf (Europe PMC) Kaynak: ORCID

EMPAGLIFLOZIN IS MORE EFFECTIVE IN REDUCING MICROALBUMINURIA AND ALT LEVELS COMPARED WITH DAPAGLIFLOZIN: REAL LIFE EXPERIENCE.

Acta endocrinologica (Bucharest, Romania : 2005), 2020

DOI 10.4183/aeb.2020.59 PMID 32685040 7 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID